Integrated Quantitative Investments LLC Acquires 9,849 Shares of Universal Health Services, Inc. $UHS

Integrated Quantitative Investments LLC increased its stake in Universal Health Services, Inc. (NYSE:UHS) by 490.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,858 shares of the health services provider’s stock after purchasing an additional 9,849 shares during the quarter. Universal Health Services makes up approximately 0.6% of Integrated Quantitative Investments LLC’s investment portfolio, making the stock its 17th biggest position. Integrated Quantitative Investments LLC’s holdings in Universal Health Services were worth $2,148,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of UHS. Farther Finance Advisors LLC increased its position in Universal Health Services by 22.9% in the second quarter. Farther Finance Advisors LLC now owns 354 shares of the health services provider’s stock worth $64,000 after buying an additional 66 shares in the last quarter. NewEdge Advisors LLC grew its stake in shares of Universal Health Services by 2.7% during the 1st quarter. NewEdge Advisors LLC now owns 2,665 shares of the health services provider’s stock valued at $501,000 after acquiring an additional 69 shares during the period. Fifth Third Bancorp increased its holdings in Universal Health Services by 5.5% in the 2nd quarter. Fifth Third Bancorp now owns 1,432 shares of the health services provider’s stock worth $259,000 after acquiring an additional 75 shares in the last quarter. Resona Asset Management Co. Ltd. increased its holdings in Universal Health Services by 0.4% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 18,244 shares of the health services provider’s stock worth $3,295,000 after acquiring an additional 78 shares in the last quarter. Finally, HighTower Advisors LLC raised its stake in Universal Health Services by 0.6% during the 1st quarter. HighTower Advisors LLC now owns 13,328 shares of the health services provider’s stock worth $2,504,000 after acquiring an additional 81 shares during the period. 86.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Warren J. Nimetz sold 3,817 shares of the firm’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $223.30, for a total value of $852,336.10. Following the completion of the transaction, the director directly owned 8,481 shares of the company’s stock, valued at approximately $1,893,807.30. This trade represents a 31.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Elliot J. Md Mba Sussman sold 965 shares of the business’s stock in a transaction on Wednesday, October 29th. The stock was sold at an average price of $225.70, for a total transaction of $217,800.50. Following the completion of the sale, the director owned 6,113 shares in the company, valued at $1,379,704.10. This represents a 13.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 16.40% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on UHS. UBS Group set a $231.00 price target on shares of Universal Health Services in a research report on Thursday, October 30th. Royal Bank Of Canada restated a “sector perform” rating on shares of Universal Health Services in a research note on Thursday, October 30th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Universal Health Services in a report on Thursday. Guggenheim raised their price target on Universal Health Services from $227.00 to $253.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Finally, Morgan Stanley set a $233.00 price objective on Universal Health Services in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $233.87.

Universal Health Services Stock Down 1.1%

Shares of UHS stock opened at $224.97 on Friday. The company’s fifty day simple moving average is $206.36 and its two-hundred day simple moving average is $188.79. Universal Health Services, Inc. has a 52 week low of $152.33 and a 52 week high of $231.37. The stock has a market cap of $14.32 billion, a P/E ratio of 10.69, a PEG ratio of 0.80 and a beta of 1.33. The company has a quick ratio of 1.19, a current ratio of 1.03 and a debt-to-equity ratio of 0.55.

Universal Health Services (NYSE:UHS) last issued its earnings results on Tuesday, October 28th. The health services provider reported $5.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.66 by $1.03. The firm had revenue of $4.50 billion for the quarter, compared to analysts’ expectations of $4.32 billion. Universal Health Services had a return on equity of 19.47% and a net margin of 8.09%.The business’s revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.71 earnings per share. Analysts predict that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.